- Clinical Trials
- April 2025
- 60 Pages
Global
From €1322EUR$1,500USD£1,139GBP
- Report
- May 2025
- 184 Pages
Global
From €3123EUR$3,545USD£2,691GBP
€3471EUR$3,939USD£2,990GBP
- Report
- May 2025
- 195 Pages
Global
From €3123EUR$3,545USD£2,691GBP
€3471EUR$3,939USD£2,990GBP
- Report
- May 2025
- 191 Pages
Global
From €3123EUR$3,545USD£2,691GBP
€3471EUR$3,939USD£2,990GBP
- Report
- May 2025
- 184 Pages
Global
From €3123EUR$3,545USD£2,691GBP
€3471EUR$3,939USD£2,990GBP
- Report
- May 2025
- 197 Pages
Global
From €3123EUR$3,545USD£2,691GBP
€3471EUR$3,939USD£2,990GBP
- Report
- April 2025
- 200 Pages
Global
From €2194EUR$2,490USD£1,890GBP
- Report
- June 2025
Global
From €4317EUR$4,900USD£3,720GBP
- Report
- April 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- April 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- April 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- March 2025
- 175 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- April 2025
- 250 Pages
Global
From €3956EUR$4,490USD£3,409GBP
- Report
- November 2024
- 150 Pages
Global
From €2863EUR$3,250USD£2,467GBP
€4273EUR$4,850USD£3,682GBP
- Report
- July 2025
- 395 Pages
Global
From €5154EUR$5,850USD£4,441GBP
- Report
- July 2025
- 384 Pages
Global
From €5154EUR$5,850USD£4,441GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more